Activated T and B lymphocytes in peripheral blood of patients with Chagas' disease. 1994

W O Dutra, and O A Martins-Filho, and J R Cançado, and J C Pinto-Dias, and Z Brener, and G L Freeman Júnior, and D G Colley, and G Gazzinelli, and J C Parra
Centro de Pesquisas René Rachou, FIOCRUZ, Belo Horizonte, Brazil.

Whole blood preparations from patients with either the indeterminate (asymptomatic) or cardiac clinical forms of chronic Trypanosoma cruzi infection were analyzed by flow cytometry using double-labeling to identify subsets of circulating lymphocytes. Several significant differences were demonstrated between the blood lymphocyte profiles of chagasic patients and non-chagasic controls. Clear increase in the percentages and actual numbers of double-positive cells of the phenotype CD3+/HLA-DR+, as well as decrease in the percentage of CD45RA+/CD4+ and CD45RA+/CD8+ T cells, indicate greater numbers of activated T cells circulating in the blood of infected patients. Consistent parallel increases were seen also in the B lymphocyte subset which stained double-positive for CD19/CD5. There were no significant differences in the circulation of these chronic chagasic patients in the CD4:CD8 ratios. Also, no substantive phenotypic differences were observed in the lymphocyte populations between the two ends of the clinical spectrum (indeterminate versus cardiac) in chronic human Chagas' disease. These observations demonstrate that increased levels of activated T cells and CD5+ B cells are present in the circulation of people with chronic Chagas' disease. These are cell phenotypes that have been associated in other conditions with autoimmune, polyclonal, and hyperimmune responses. The specificities of these activated cells and the roles they may play in resistance or pathogenesis during chronic Chagas' disease need now to be determined.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006684 HLA-DR Antigens A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS. HLA-DR,Antigens, HLA-DR,HLA DR Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

W O Dutra, and O A Martins-Filho, and J R Cançado, and J C Pinto-Dias, and Z Brener, and G L Freeman Júnior, and D G Colley, and G Gazzinelli, and J C Parra
November 2013, Clinical and experimental immunology,
W O Dutra, and O A Martins-Filho, and J R Cançado, and J C Pinto-Dias, and Z Brener, and G L Freeman Júnior, and D G Colley, and G Gazzinelli, and J C Parra
August 1977, Acta endocrinologica,
W O Dutra, and O A Martins-Filho, and J R Cançado, and J C Pinto-Dias, and Z Brener, and G L Freeman Júnior, and D G Colley, and G Gazzinelli, and J C Parra
April 1977, Ginekologia polska,
W O Dutra, and O A Martins-Filho, and J R Cançado, and J C Pinto-Dias, and Z Brener, and G L Freeman Júnior, and D G Colley, and G Gazzinelli, and J C Parra
November 1994, Immunopharmacology and immunotoxicology,
W O Dutra, and O A Martins-Filho, and J R Cançado, and J C Pinto-Dias, and Z Brener, and G L Freeman Júnior, and D G Colley, and G Gazzinelli, and J C Parra
September 1978, Vrachebnoe delo,
W O Dutra, and O A Martins-Filho, and J R Cançado, and J C Pinto-Dias, and Z Brener, and G L Freeman Júnior, and D G Colley, and G Gazzinelli, and J C Parra
January 1976, Acta haematologica,
W O Dutra, and O A Martins-Filho, and J R Cançado, and J C Pinto-Dias, and Z Brener, and G L Freeman Júnior, and D G Colley, and G Gazzinelli, and J C Parra
July 1999, The Journal of infectious diseases,
W O Dutra, and O A Martins-Filho, and J R Cançado, and J C Pinto-Dias, and Z Brener, and G L Freeman Júnior, and D G Colley, and G Gazzinelli, and J C Parra
August 1978, Journal of the National Cancer Institute,
W O Dutra, and O A Martins-Filho, and J R Cançado, and J C Pinto-Dias, and Z Brener, and G L Freeman Júnior, and D G Colley, and G Gazzinelli, and J C Parra
July 1973, Clinical immunology and immunopathology,
W O Dutra, and O A Martins-Filho, and J R Cançado, and J C Pinto-Dias, and Z Brener, and G L Freeman Júnior, and D G Colley, and G Gazzinelli, and J C Parra
January 1979, Endokrynologia Polska,
Copied contents to your clipboard!